Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

HHS expands health reimbursement coverage

HHS, with the Departments of Labor and Treasury, has issued a new rule to expand the use of health reimbursement coverage, which provide tax-preferred funds for employees to buy their own insurance on the individual market.

Thumbnail

Huffington Post highlights the GoFundMe reality of healthcare costs

The sky-high costs of receiving medical care and the reality of asking for help to pay those bills are being highlighted by The Huffington Post in a series titled “Life and Death: Stories from Inside America’s GoFundMe Health Care System.”

Thumbnail

CMS asks for input in efforts to reduce paperwork

CMS wants to reduce the paperwork burden for the healthcare industry and is asking for stakeholder input on its initiative, Patients over Paperwork, the agency announced June 6.

 

Thumbnail

Washington Post: Pfizer hid effectiveness of drug to reduce Alzheimer’s risk

Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.

 

Thumbnail

Partners Healthcare won’t buy Care New England

Partners HealthCare, a Boston-based health system, has backed out of its planned acquisition of Care New England

Thumbnail

CVS to expand HealthHub concept

Amid an ongoing court review of its $69 billion merger with health insurer Aetna, CVS Health isn’t slowing down in its plans to expand, according to executives who spoke at the company’s investor day on June 4.

 

Thumbnail

Top-selling drugs keep rising in price

Brand-name drugs are likely to keep rising in price, even though the top-selling ones have been available for years and have already seen their costs skyrocket, according to a new study published in JAMA.

 

Thumbnail

CVS to defend $69B merger with Aetna in upcoming court proceeding

CVS Health is gearing up to defend its $69 billion takeover of the nation’s third-largest health insurer, Aetna, The Wall Street Journal reported.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup